Introduction of Merck serono

Merck Serono is an innovative prescription drug business unit of Merck, a global pharmaceutical and chemical group headquartered in Geneva, Switzerland. Merck Serono is committed to discovering, developing, producing and selling innovative small molecules and biopharmaceutical products to help patients solve their unmet medical needs. In the United States and Canada, Merck Serono conducts business under the name of EMD Serono. Headquartered in Beijing, Merck Serono China has more than 65,438+0,000 employees and its business covers the whole country. At present, there are 9 fields of 17 drugs in China, and more than 10 new drugs will be listed in the next few years. Merck kgaa announced that it will invest 650 million yuan to build a new pharmaceutical factory in Nantong, China. Merck said that the pharmaceutical factory will become Merck Serono's second largest pharmaceutical factory in the world.